Evaluation of Serum levels of epidermal growth factor (EGF) in Patients with alopecia areata

Serum Interleukin 19 in Patients with Alopecia Areata

Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata

Serum Epidermal Growth Factor Level and its Relation to Severity of Alopecia Areata

Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study

Serum MicroRNA-155 Expression Level as a Novel Biomarker in Alopecia Areata Patients

Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata

Serum Level of Programmed Death Ligand1 in Alopecia Areata Patients in Relation to Disease Severity

Serum Level of Survivin in Patients with Alopecia Areata and its Association with Disease Severity and Progression

Serum Progranulin and Insulin Resistance Evaluation in Male Androgenetic Alopecia Patients